Position
Chief Scientific Officer
Company
Hyku Biosciences
LexingtonBiotechnologyHealth CareTherapeuticsDescription
Hyku Biosciences announced the appointment of Keith Wilcoxen, Ph.D., as Chief Scientific Officer. Dr. Wilcoxen brings more than 25 years of experience advancing new therapies through preclinical and early clinical development, with a strong history of accomplishments in the biopharmaceutical industry.
Quick answer
Hyku Biosciences Names Keith Wilcoxen as Chief Scientific Officer (March 19, 2025). Hyku Biosciences is based in Lexington, Massachusetts, United States.
- Who is the new Chief Scientific Officer at Hyku Biosciences?
- Hyku Biosciences named Keith Wilcoxen Chief Scientific Officer, announced March 19, 2025.
- What did Hyku Biosciences announce on March 19, 2025?
- Hyku Biosciences announced the appointment of Keith Wilcoxen, Ph.D., as Chief Scientific Officer. Dr. Wilcoxen brings more than 25 years of experience advancing new therapies through preclinical and early clinical development, with a strong history of accomplishments in the biopharmaceutical industry.
- What does Hyku Biosciences do?
- Hyku is a biotechnology company based in the greater Boston area, utilizing its proprietary discovery platform to inhibit disease targets that are challenging to address with conventional approaches.
- Where is Hyku Biosciences based?
- Hyku Biosciences is based in Lexington, Massachusetts, United States.
- Which similar companies made leadership changes around the same time?
- Zenas BioPharma (March 19, 2025), Bristol Myers Squibb (March 20, 2025), Immuneering (March 20, 2025) and Nanoscope Therapeutics (March 20, 2025) also announced leadership changes within 45 days of Hyku Biosciences.
Source: Fundz verified event record.
Other recent leadership changes in Therapeutics and Biotechnology
Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.
- Zenas BioPharma Appoints Lisa von Moltke, M.D. as Head of Research and Development and Chief Medical Officer (March 19, 2025)
- Bristol Myers Squibb Appoints Osama Braiwish as General Manager for Saudi Arabia and Gulf Countries (March 20, 2025)
- Igor Matushansky, MD, PhD, Joins Immuneering as Chief Medical Officer (March 20, 2025)
- Nanoscope Therapeutics Appoints Ademola Daramola as Vice President, Quality and Compliance (March 20, 2025)
- Dyne Therapeutics Appoints Erick J. Lucera as Chief Financial Officer (March 20, 2025)
- Exubrion Therapeutics Appoints Jennifer Kirk as Chief Executive Officer (March 18, 2025)
Who to call at Hyku Biosciences, and when
A new leader at Hyku Biosciences brings new priorities and often new vendors. The first weeks are when they listen.
- An alert the day Hyku Biosciences raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Hyku Biosciences, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Hyku Biosciences. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Hyku Biosciences changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Hyku Biosciences changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.